Kinase activity profiling reveals active signal transduction pathways in pediatric acute lymphoblastic leukemia: a

Naomi E van der Sligte1, Frank J G Scherpen, Tiny G J Meeuwsen-de Boer

  • 1Division of Pediatric Oncology/Hematology, Department of Pediatrics, Beatrix Children's Hospital, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.

Proteomics
|November 26, 2014
PubMed

Insights

Kinome profiling reveals key signaling pathways in pediatric acute lymphoblastic leukemia (ALL). This approach identifies potential drug targets to address treatment resistance in ALL patients.

Area of Science:

  • Oncology
  • Biochemistry
  • Molecular Biology

Background:

  • Approximately 20% of acute lymphoblastic leukemia (ALL) patients experience relapse despite intensive chemotherapy.
  • Kinase activity profiling offers insights into active signaling pathways and potential therapeutic targets in ALL.
  • Identifying novel druggable targets is crucial for bridging the gap between drug development and ALL treatment.

Purpose of the Study:

  • To perform kinome profiling on pediatric ALL samples to identify signaling proteins relevant to the disease.
  • To characterize activated signaling pathways in both B-cell precursor ALL (BCP-ALL) and T-cell ALL (T-ALL).
  • To identify differentially phosphorylated peptides between BCP-ALL and T-ALL for potential targeted therapy.

Main Methods:

  • Kinome profiling was conducted on 20 pediatric ALL samples (14 BCP-ALL, 6 T-ALL).
  • Peptide phosphorylation was analyzed to identify commonly activated and differentially phosphorylated signaling proteins.
  • The efficacy of a selected target (HGFR_Y1235) was tested as a proof of principle.

Main Results:

  • 250 peptides were commonly activated in both BCP-ALL and T-ALL, involving MAPK, PI3K/Akt, and cell cycle/p53 pathways.
  • 27 peptides showed differential phosphorylation between BCP-ALL and T-ALL.
  • Ten peptides were more phosphorylated in BCP-ALL, and 17 were more phosphorylated in T-ALL.

Conclusions:

  • Kinome profiling is an effective method for studying active signaling in ALL.
  • This technique can identify potential druggable targets for ALL treatment.
  • Targeting specific signaling pathways may help overcome resistance in ALL.

Related Concept Videos

Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
8.0K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
19.7K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
14.3K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
9.5K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.5K
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
21.3K